{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:14:00Z","timestamp":1775726040117,"version":"3.50.1"},"reference-count":31,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Mass Spectrom"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Pacritinib is a novel medication with certain limitations and unknowns in therapeutic applications. Due to the increased frequency of side effects such as fungal infections, nausea, and vomiting, the potential for drug interactions is significantly heightened. This study aimed to establish a quantitative analysis method for pacritinib and investigate its interactions with other drugs. A quantitative detection method for pacritinib in rat plasma was developed using LC\u2010MS\/MS, with ibrutinib as an internal standard. This method was subsequently applied to pharmacokinetic and drug\u2013drug interaction studies in rats. The method demonstrated good linearity within the range of 1\u20131500\u2009ng\/mL, with an LLOQ of 1\u2009ng\/mL. Both intraday and interday precisions (RSD%) were less than 14.52%, and the recovery, matrix effect, and stability met FDA guidelines. The method proved effective for the quantitative detection of pacritinib in rat plasma. Pharmacokinetic studies revealed that isavuconazole significantly inhibited the metabolism of pacritinib compared to voriconazole, resulting in a 2.5\u2010fold increase in\n                    <jats:italic>AUC<\/jats:italic>\n                    <jats:sub>\n                      (0\u2212\n                      <jats:italic>t<\/jats:italic>\n                      )\n                    <\/jats:sub>\n                    , a 2.6\u2010fold increase in\n                    <jats:italic>AUC<\/jats:italic>\n                    <jats:sub>(0\u2013\u221e)<\/jats:sub>\n                    , and a 3.0\u2010fold increase in\n                    <jats:italic>C<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>max<\/jats:italic>\n                    <\/jats:sub>\n                    . Additionally, the\n                    <jats:italic>CLz<\/jats:italic>\n                    \/\n                    <jats:italic>F<\/jats:italic>\n                    value in the isavuconazole group decreased by 67%. This study successfully established a reliable LC\u2010MS\/MS method for detecting pacritinib plasma concentrations in rats. The findings indicate that isavuconazole is more likely to increase pacritinib blood exposure than voriconazole, highlighting the need for caution when combining isavuconazole with pacritinib in clinical practice.\n                  <\/jats:p>","DOI":"10.1002\/jms.5142","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T03:19:23Z","timestamp":1745983163000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a Rapid LC\u2010MS\/MS Method and Its Application for the Pharmacokinetic Analysis of Pacritinib in Rats"],"prefix":"10.1002","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3459-6777","authenticated-orcid":false,"given":"Ya\u00a0Meng","family":"Wu","sequence":"first","affiliation":[{"name":"Affiliated Yueqing Hospital Wenzhou Medical University  Wenzhou Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zheng","sequence":"additional","affiliation":[{"name":"Affiliated Yueqing Hospital Wenzhou Medical University  Wenzhou Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luo\u00a0Yi","family":"Huang","sequence":"additional","affiliation":[{"name":"Affiliated Yueqing Hospital Wenzhou Medical University  Wenzhou Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing\u00a0Huan","family":"Ni","sequence":"additional","affiliation":[{"name":"Institute of Molecular Toxicology and Pharmacology, School of Pharmaceutical Sciences Wenzhou Medical University  Wenzhou Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng\u00a0Fei","family":"Tang","sequence":"additional","affiliation":[{"name":"Affiliated Yueqing Hospital Wenzhou Medical University  Wenzhou Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian\u00a0Chang","family":"Qian","sequence":"additional","affiliation":[{"name":"Institute of Molecular Toxicology and Pharmacology, School of Pharmaceutical Sciences Wenzhou Medical University  Wenzhou Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhong\u00a0Xiang","family":"Xiao","sequence":"additional","affiliation":[{"name":"Affiliated Yueqing Hospital Wenzhou Medical University  Wenzhou Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun\u00a0Lei","family":"Li","sequence":"additional","affiliation":[{"name":"Affiliated Yueqing Hospital Wenzhou Medical University  Wenzhou Zhejiang China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2020.08.018"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26857"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.2174\/1871520623666230320120915"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26050"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.09.023"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-22-0323"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.32746"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00438-4"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14051001"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00495-3"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007524"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-016-0367-x"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S334727"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000822"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2018.1500456"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.biochem.9b00156"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061617"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S149069"},{"key":"e_1_2_9_20_1","unstructured":"CTI BioPharma Corp \u201cVONJOTM (Pacritinib) Capsules for Oral Use Initial U.S. Approval \u201d (2023). Available from:http:\/\/www.sccessdata.fda.gov\/drugsatfda_docs\/label\/2023\/208712s001bl.pdf. Accessed August 15 2023."},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040620715586527"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189670"},{"key":"e_1_2_9_23_1","first-page":"122","article-title":"Development and Validation of an LC\u2010MSMS Method for the Quantitation of Pacritinib; Application of Kinetics in Rabbits","volume":"1145","author":"Sunkara P. S.","year":"2020","journal-title":"Journal of Chromatography B"},{"issue":"6","key":"e_1_2_9_24_1","first-page":"912","article-title":"Metabolism and Disposition of Pacritinib (SB1518), an Orally Active Janus Kinase 2 Inhibitor in Preclinical Species and Humans","volume":"44","author":"Jayaraman R.","year":"2016","journal-title":"Drug Metabolism and Disposition"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.5525"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0954-2"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01718-y"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S354270"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.31.5.540"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.12.305"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1168852"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.15844"}],"container-title":["Journal of Mass Spectrometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jms.5142","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jms.5142","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jms.5142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:24:17Z","timestamp":1775723057000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/jms.5142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["10.1002\/jms.5142"],"URL":"https:\/\/doi.org\/10.1002\/jms.5142","archive":["Portico"],"relation":{},"ISSN":["1076-5174","1096-9888"],"issn-type":[{"value":"1076-5174","type":"print"},{"value":"1096-9888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"2025-03-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e5142"}}